Suppr超能文献

呋喃妥因在印度多药耐药情况下的优势与局限性

Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario.

作者信息

Shakti Laishram, Veeraraghavan Balaji

机构信息

Department of Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.

出版信息

Indian J Med Microbiol. 2015 Oct-Dec;33(4):477-81. doi: 10.4103/0255-0857.167350.

Abstract

Infections caused by antibiotic resistant pathogens are of significant concern and are associated with higher mortality and morbidity. Nitrofurantoin is a broad-spectrum bactericidal antibiotic and is effectively used to treat urinary tract infections (UTIs) caused by E. coli, Klebsiella sp., Enterobacter sp., Enterococcus sp. and Staphylococcus aureus. It interfere with the synthesis of cell wall, bacterial proteins and DNA of both Gram positive and Gram negative pathogens. Nitrofurantoin has been used successfully for treatment and prophylaxis of acute lower urinary tract infections. With the emergence of antibiotic resistance, nitrofurantoin has become the choice of agent for treating UTIs caused by multi-drug resistant pathogens.

摘要

由抗生素耐药性病原体引起的感染备受关注,且与更高的死亡率和发病率相关。呋喃妥因是一种广谱杀菌抗生素,可有效用于治疗由大肠杆菌、克雷伯菌属、肠杆菌属、肠球菌属和金黄色葡萄球菌引起的尿路感染(UTIs)。它干扰革兰氏阳性和革兰氏阴性病原体的细胞壁、细菌蛋白质和DNA的合成。呋喃妥因已成功用于治疗和预防急性下尿路感染。随着抗生素耐药性的出现,呋喃妥因已成为治疗由多重耐药病原体引起的尿路感染的首选药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验